Variable | Caucasian | Indian/Pakistani | African-American | Hispanic | P value* |
---|---|---|---|---|---|
Histology | Â | Â | Â | Â | 0.02* |
In situ---Ductal | 31998 (12.1) | 142 (12.0) | 4409 (12.7) | 1907 (11.8) | Â |
In situ---Lobular | 6641 (2.5) | 21 (1.8)* | 648 (1.9) | 330 (2.0) | Â |
In situ--Mixed | 6243 (2.4) | 41 (3.5)* | 984 (2.8) | 420 (2.6) | Â |
Histology | Â | Â | Â | Â | < 0.0001* |
Invasive--Ductal | 173174 (65.6) | 817 (69.1)* | 24254 (69.6) | 10858 (67.3) | Â |
Invasive---Lobular | 21725 (8.2) | 50 (4.2)* | 1752 (5.0) | 1023 (6.3) | Â |
Invasive--Mixed | 21853 (8.3) | 96 (8.1) | 2253 (6.5) | 1322 (8.2) | Â |
Inflammatory carcinoma | 2218 (0.8) | 16 (1.4)* | 537 (1.5) | 265 (1.6) | Â |
Estrogen Receptor (ER) | Â | Â | Â | Â | 0.0688* |
Positive | 130267(79.3) | 463 (71.9)* | 12902 (62.6) | 6984 (72.3) | Â |
Negative | 34040 (20.8) | 181 (28.1)* | 7724 (37.5) | 2673 (27.7) | Â |
Progesterone Receptor (PR) | Â | Â | Â | Â | 0.0260* |
Positive | 108451(68.2) | 391 (62.2)* | 10548 (53.1) | 5758 (62.5) | Â |
Negative | 50533 (31.8) | 238 (37.8)* | 9315 (46.9) | 3449 (37.5) | Â |
ER/PR | Â | Â | Â | Â | 0.0095* |
Positive/Positive | 103767 (78.2) | 377 (69.4)* | 9702 (58.9) | 5408 (70.3) | Â |
Negative/Negative | 28994 (21.8) | 166 (30.6)* | 6772 (41.1) | 2285 (29.7) | Â |